You can buy or sell Humanigen and other stocks, options, and ETFs commission-free!
Humanigen, Inc. Common Stock, also called Humanigen, is a clinical-stage biopharmaceutical company. It engages in the development of cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor neutralization and gene-knockout platforms. The company was founded by Jeng-Horng Her & Robert F. Balint on March 15, 2000 and is headquartered in Burlingame, CA. The listed name for HGEN is Humanigen, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 15, Pre-Market